Combination Treatment for Moderate to Severe Acne

Medicis Global Service

Status and phase: Completed; Phase 4

Conditions: Acne

Treatments: Drug: Minocycline, Clindamycin, Tretinoin, Benzoyl Peroxide

Study type: Interventional

Funder types: Industry

Identifiers

NCT01206348

MP-0104-28

Details and patient eligibility

About

To determine if a combination of three currently approved acne products are safe and effective for the treatment of moderate to severe acne

Full description

A Phase IV, Open-Label Study Evaluating the treatment for Combination Acne Therapy.

Enrollment: 97 patients

Sex: All

Ages: 12 to 30 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• moderate to severe acne, IGA = 3 or 4 (Investigator Global Assessment)

Exclusion criteria

• pregnancy and allergies

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

97 participants in 1 patient group

Open Label Combination

Experimental group

Description:

Solodyn, Ziana, Triaz FC

Treatment:

Drug: Minocycline, Clindamycin, Tretinoin, Benzoyl Peroxide